Loading insider details...
Beta
Latest Form 4 (Sep 24, 2026): Tax Withholding of 115 LGND shares, $34.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Tax Withholding | 115 | $34.3K |
| Sep 14, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Sale | 1,200 | $342.0K |
| Sep 10, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 64,000 | n/a |
| Jun 9, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 836 | n/a |
| Sep 24, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Tax Withholding | 115 | $19.6K |
| Jun 10, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 1,209 | n/a |
| Jun 19, 2024 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 1,252 | n/a |
| Sep 26, 2023 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 2,285 | n/a |